Pilot Project diGItal
The Pilot Project diGItal shows how electronic product information leaflets (EPILs) for medicines can be used and promotes their widespread implementation.
The Pilot Project diGItal shows how electronic product information leaflets (EPILs) for medicines can be used and promotes their widespread implementation.
The Pilot Project EPIL is currently being launched in Germany as an initiative of the manufacturers’ associations BPI, Pharma Deutschland, Pro Generika and vfa.
diGItal Forum
October 1st, 2025
On-site participation:
Quadriga Forum,
10117 Berlin
More information here
Electronic product information leaflets (EPILs) are becoming increasingly important as they offer a variety of advantages for all relevant stakeholders.
Patients benefit from improved readability, easier access, more up-to-date information and environmental sustainability.
At the regulatory level, electronic product information leaflets are also gaining significance. Both at the European and national level, there are ongoing discussions about the legal integration of electronic product information.
This pilot project aims to test various use cases in order to gain important insights into the use of electronic product informnation leaflets.
Our goal is to promote the widespread use of electronic product information leaflets!
For all the latest information, please visit our LinkedIn channel.